The recent development of hybridoma technology has enlarged our understanding of cell surface molecules, especially those of lymphoid organs. T cell leukemia, which is a common neoplasm of the mouse, and its normal counterpart, the thymocyte, have been a major focus for studying cell surface antigens (1). It has been generally accepted that, in the mouse embryo, thymic stem cells are derived from either the yolk sac or the fetal liver. Shortly after the stem cells enter into the thymus, they begin to proliferate and give rise to thymocytes in the cortex and medulla, where they can be divided into functional subclasses of T iymphocytes having a wide repertory of antigen specificity (2). Serological analysis has revealed that this process of differentiation of thymic lymphocytes involves a number of marked changes in surface antigens, Thy-1, Lyt-l,2,3, TL and other T cell differentiation antigens (3-5). Almost all of these antigens, except for the TL systems, are quantitative rather than qualitative features. The presence of TL antigen is restricted to adult thymocytes and leukemias of thymic origin, and the mechanism of regulation of gene coding for this antigen is of particular interest. However, no report has yet appeared that describes the antigens expressed predominantly on fetal thymocytes and leukemia cells.
expressed on cells of adult lymphoid tissues including thymus, spleen, lymph nodes, and bone marrow. In this report, production of a mouse monoclonal antibody detecting this receptor on fetal thymocytes is described. Biochemical properties of the antigen recognized, which was provisionally designated fetal thymocyte antigen-l, FT-1, were also investigated.
Materials and Methods
Animals and Leukemias. A/J, AKR/J, BALB/c, CBA/J, C57BL/6, C3H/HeN, DBA/2, NZB, and SJL mice were supplied by the Omura Institute for Laboratory Animals (Zama, Kanagawa, Japan). GR mice were kindly provided by Dr. T. Sakakura, Laboratory of Experimental Pathology, Aichi Cancer Center Research Institute, Nagoya, Japan.
The leukemias used were kindly given to us by Dr. L. J. Old of Memorial SloanKettering Cancer Institute, New York, and Dr. J. Hilgers, The Netherlands Cancer Institute, The Netherlands. YAC-1 and GRSL cultured cell lines were maintained in RPMI 1640 medium supplemented with 5% fetal calf serum (FCS). All other leukemias were carried in the ascites form.
Cell Fusion and Cloning. BALB/c mice were hyperimmunized with 1 × 107 GRSL cells. 3 d after the booster injection, 5 × 107 spleen cells from the mice were fused with X63-Ag8.653 cells in the presence of polyethylene glycol (PEG; mol wt 1,500) (9, I0) . Then the cells were plated in a 96-well culture plate (Costar #3596; Costar, Data Packaging, Cambridge, MA) and grown in medium containing hypoxanthine, aminopterin, and thymidine (HAT). 3 wk after the fusion, the culture supernatants were screened in the immunofluorescence study. Cells from these wells were cloned by limiting dilution on feeder layers of BALB/c thymocytes. A clone derived from one well (M6) was used for the study described here. As M6 antibody was determined to be of the IgM isotype, the antibody in the supernatant was precipitated by (NH4)2SO4, and fractionated by Sephadex For immunoprecipitation, the lysate was incubated with 20 #1 of anti-FT-1 for 2 h at 0°C, and then with 50 #1 of goat anti-mouse IgM serum for an additional 10-20 h. The resulting immune complex was mixed with 200 ~1 of 10% fixed Staphylococcus aureus Cowan I strain organisms (Bethesda Research Laboratories, Inc., Gaithersburg, MD) for 60 min at 0°C. The precipitate was washed extensively and then bound antigens were released by boiling for 3 min in sample buffer containing 20% glycerol, 4% sodium dodecyl sulfate (SDS), 120 mM Tris HCI, pH 6.8, and 0.005% bromphenol blue with or without 5% 2-mercaptoethanol.
Immunofluorescence and Qvtotoxicity Test. For tissue distribution studies, 1.0 x 106 lymphoid cells were incubated for 30 min at 4°C in 50 IA of MEM containing 5 t~g of biotinconjugated anti-FT-1. The cells were then washed three times and stained for 30 min at 4°C with 1/~g of FITC-avidin in 50 #1 of MEM. FITC-monoclonal anti-Thy-l.2 antibody used at a 1:40 dilution was kindly provided by Dr. K. Okumura, University of Tokyo, Tokyo, Japan. 1 #g of FITC-DBA in 50/~! of MEM was used for staining. The absorption test and complement-dependent cytotoxicity assay were carried out according to the method described previously (11) .
Isolation of DBA Receptors. DBA receptors were isolated from GRSL cells according to the method described previously (8) . Briefly, the detergent lysate of GRSL cells was applied to a DBA-Sepharose 4B column equilibrated with the elution buffer (0.5% NP- Polyacrylamide Gel Electrophoresis (PAGE) and Fluorography. The DBA receptors were fractionated by 7.5% SDS-PAGE under reducing or nonreducing conditions. After the electrophoresis, the gels were stained with Coomassie Brilliant blue, destained with 10% acetic acid and then processed for fluorography. Briefly, the gels were soaked in 10 vol of 1 M sodium salicylate for 30 min (12) and dried on Whatman 3 MM paper and then exposed to X-ray film (Kodak X-Omat AR) at -70°C.
Two-dimensional Gel Electrophoresis. FT-1 antigens labeled with [3HI galactose were electrophoresed in two dimensions according to the method developed by O'Farrell (13).
The first dimension separation was by nonequilibrium pH-gradient electrophoresis. The second dimension SDS gel electrophoresis was carried out in 10-16% acrylamide gradient gel.
Results
Tissue Distribution. Cell hybridization was performed between BALB/c myeIoma, X63-Ag8.653 cells, and the lymphocytes of BALB/c mice that were immunized with GRSL cells. One of the hybrids, M6, which reacted with fetal thymocytes but not with adult thymocytes, was subcloned twice by limiting dilution.
Cells from different tissues of A/J mice were incubated with the biotinylated M6 antibody and then stained with FITC-avidin. As summarized in Table I, M6 Fetal thymocytes positive for FT-1 or Thy-1 were determined by immunofluorescent staining as described in Materials and Methods.
antibody brightly stained fetal thymocytes, whereas there were no positive cells in fetal liver and adult thymus. No positive cells were observed in the spleen, lymph node, or bone marrow. The absorption study, testing for residual cytotoxicity of M6 antibody against GRSL cells, confirmed the above results and showed that the antibody did not react with the nonlymphoid tissues liver, kidney, and brain. Therefore, the antigen detected by M6 antibody was provisionally called fetal thymus antigen-l, FT-1.
Ontogeny of FT-1 Antigen. Strain distribution studies showed that anti-FT-1 (M6 antibody) reacted with the fetal thymocytes of all the inbred mouse strains examined, including BALB/c. As shown in Table II , the proportion of fetal thymocytes positive for FT-1 sharply decreased with increase in gestation time. A small percentage of positive cells still remained in the thymus of neonatal mice, but almost completely disappeared from that of adult mice (7-8 wk) . In contrast, Thy-l-positive cells increased in inverse proportion in the fetal thymus. The ontogenic appearance of FT-! antigen seemed to be almost completely identical to that of DBA lectin receptor as reported previously (7) .
FT-1 Antigen on Leukemia Cells. Since anti-FT-1 antibody was raised against GRSL cells, it can be assumed that FT-1 antigen is also expressed on the other leukemia cells. Therefore, a number of mouse leukemias were tested for the expression of FT-1 antigen (Table III) by an immunofluorescence study using biotinylated anti-FT-1 and FITC-avidin. In addition to GRSL cells, cells of 6 out of 14 leukemias tested were brightly stained; ASL-1, RADA-1, and YAC-1 in strain A/J, RL~-I in strain BALB/c, and DBA,SL-2 in strain DBA were positive, but AKSL-2, BW5147, and K36 derived from a high leukemic mouse strain, AKR, were all negative.
Biochemical Characterization of FT-1 Antigen. For the estimation of the molecular weight of FT-1 antigen, immunoprecipitation experiments were carried out with NP-40-solubilized antigen from [3H] galactose-labeled GRSL cells, and then the precipitates were run on 7.5% acrylamide SDS gels. The fluorograph shown in Fig. 1 indicates that the apparent molecular weight of FT-1 is ~130,000. A similar result was obtained when immunoprecipitates were derived from cells metabolically labeled by the incorporation of [~S]methionine, although 55,000 and other minor bands were also obtained (Fig. 2) . These results clearly indicate that FT-1 antigenic determinants of the leukemic cells reside on the 130,000-dalton glycoproteins. Further biochemical characterization of FT-1 antigen by Relationship between FT-I Antigen and DBA Receptor. C o n c e r n i n g the o n t o g e n y a n d the e x p r e s s i o n o f l e u k e m i a cells o f FT-1 a n t i g e n ( T a b l e s II a n d III), t h e r e a r e a n u m b e r o f similarities b e t w e e n F T -1 a n t i g e n a n d D B A lectin r e c e p t o r s . In o r d e r to clarify the r e l a t i o n s h i p b e t w e e n these two m o l e c u l e s on G R S L l e u k e m i c cells, the following experiments were carried out. First, GRSL tumor cells were lysed in 0.5% NP-40 extraction medium and the supernatant was applied to a column of DBA Sepharose 4B. 5 #g of the receptor molecules eluted from the DBA Sepharose 4B column by 0.1 M N-acetylgalactosamine was mixed with 50 ~1 of anti-FT-1 antibody. After the precipitate was spun down, the supernatant was serially diluted and tested for residual cytotoxicity against YAC-1 cells. Fig.  4 shows that the cytotoxic activity of anti-FT-1 antibody was absorbed with DBA receptor. Second, it was demonstrated that DBA receptors were immunoprecip-itated by anti-FT-1. Although the molecular weight of [3H]galactose-labeled DBA receptors was slightly lower than that of FT-1 (Fig. 5A) , these receptor molecules were specifically absorbed with anti-FT-1 and no precipitation band was observed as shown in Fig. 5B . However, an unrelated IgM hybridoma antibody, anti-FT-2 used as a control, could not absorb DBA receptors so that the precipitation band remained (Fig. 5C) . These results strongly suggest that the FT-1 molecule resides on the DBA lectin receptor. Discussion The present study demonstrated a unique cell surface antigen designated FT-1, which is expressed on fetal thymocytes of all mouse strains examined, but not on thymocytes or other lymphoid cells of adult mice. This antigen is present also on some leukemia cells, and it is found on the receptor molecules for DBA lectin on GRSL leukemia cells. One of the interesting features of FT-1 antigen is the timing of its expression in connection with thymocyte ontogeny. A majority of fetal thymocytes at 13 d gestation express FT-1 antigen, whereas no positive cells are found in the fetal liver. Therefore, FT-1 antigen seems to appear as soon as the stem cells have reached the thymus. The proportion of FT-1 ÷ cells then declined sharply with increase in the time of gestation, while Thy-1 + cells increased in inverse proportion. The results suggest that FT-1-stem cells acquire FT-1 antigen, and then differentiate into Thy-1 + FT-1-cells under the influence of thymic epithelial cells, although the possibility remains that Thy-1 + cells are derived from a minor FT-1-population in the embryonic thymus. In neonatal mice, a small percentage of FT-1 ÷ cell still remain in the thymus, but these cells almost completely disappear from the adult thymus, spleen, lymph nodes, and bone marrow. The differentiation of mouse T cells has been extensively studied by use of cell surface antigens (14) (15) (16) . In the first stage of intrathymic differentiation, stem cells migrate into the cortical area of the thymus, where they acquire Thy-1, TL, and Lyt antigens. These cortical cells, which have Thy-1 antigen in high density, are cortisone-sensitive and relatively large in size. With further maturation, TL antigens are lost and then Thy-1 diminishes in density. Thereafter, they migrate to the thymus medulla where they are medium-sized cells and are resistant to cortisone. Finally they migrate from the thymus medulla to the peripheral lymphoid organs. In contrast to the differentiation sequence within the adult thymus as described above, little is known about the surface antigens of fetal thymocytes before they acquire a number of T cell antigens. Although rabbit anti-asialo GM1 antibody with potent anti-natural killer (NK) activity (17) has been shown to react with fetal thymocytes (18) , it is evident that anti-FT-1 marks fetal thymocytes more specifically. Thus, FT-1 antigen will be a useful marker for studying the early stages of T cell ontogeny. Experiments are now in progress to elucidate the mechanism of the acquisition as well as the processing of FT-1 in the thymus of the fetal mouse.
t w o -d i m e n s i o n a l gel e l e c t r o p h o r e s i s c o n f i r m e d t h e a b o v e r e s u l t s i n d i c a t i n g size h o m o g e n e i t y . A s s h o w n in Fig. 3, h o w e v e r , t h e f l u o r o g r a p h i c p a t t e r n o f [3H] g a l a c t o s e -l a b e l e d F T -1 a n t i g e n s h o w s a f a m i l y o f g l y c o p r o t e i n s w i t h e x t e n s i v e c h a r g e h e t e r o g e n e i t y .
It is frequently said that the presence of embryonic tissue antigen is shared with tumor antigen. However, in lymphoid tissues, such antigens have not ever been serologically defined to date. Since FT-1 is present on fetal thymocytes and some leukemia cells, this is probably the first example of an oncofetal antigen of a mouse T cell leukemia. Therefore, FT-1 antigen will be as important as TL antigen for understanding the mechanism underlying the activation of normally silent genetic information in leukemic cells.
The molecular weight of FT-1 antigen on leukemic cells was estimated to be 130,000 by means of [SH]galactose labeling followed by immunoprecipitation. FT-1 antigen biosynthetically labeled with [35S] methionine also appeared as a major band with a mol wt 130,000. The other minor bands, especially the 55,000 band, were also brought down. It is possible to assume that 55,000 molecule is an intracellular form of FT-1 antigen that is not detected by sugar labeling. However, further experiments are necessary to study kinetics of FT-1 antigen synthesis in the cells. Two-dimensional gel electrophoresis revealed that FT-1 antigenic determinants appear to reside on a family of glycoproteins with extensive charge heterogeneity. In these biochemical studies, we did not succeed in detecting FT-1 molecules on fetal thymocytes so far attempted, probably because the number of fetal thymocytes used for these experiments was not sufficient. The molecule defined by anti-FT-1 is clearly different from other T cell differentiation antigens in terms of biochemical properties and tissue distribution. Considering the reciprocal appearance of Thy-1 ÷ cells and FT-1 ÷ cells, it could be possible to assume that the FT-1 molecule is a precursor of other T cell differentiation antigens. Further biochemical and genetic analysis of FT-1 antigen will contribute to understanding of the ontogenic development of T cells as well as leukemogenesis of T cell leukemias.
Summary
A mouse monoclonal antibody (IgM) was obtained by cell hybridization between X63-Ag8.653 myeloma cells and spleen cells from a BALB mouse that was immunized with GRSL leukemia cells of the GR strain. This antibody identified a unique fetal antigen, which is expressed exclusively on embryonic thymocytes of all strains tested. Therefore, the antigen defined was named fetal thymus antigen-l, FT-1. The proportion of FT-1 ÷ fetal thymocytes detected by immunofluorescence assay sharply decreases as gestation time increases, and finally they disappear from the thymus. On the other hand, Thy-1 + cells increase in inverse proportion. The immunofluorescence studies and absorption tests showed that FT-1 antigen is not detectable on brain, liver, kidney, or lymphoid tissue cells of adult mice. However, it is expressed on some leukemia cells of various mouse strains, which demonstrated that this is the first example of an oncofetal antigen of a mouse leukemia. The molecular weight of FT-1 antigen on leukemia cells was estimated to be 130,000 by means of biosynthetic labeling with [SH]galactose and [SSS]methionine. The two-dimensional gel electrophoresis pattern of FT-1 antigen shows a family of glycoproteins with extensive charge heterogeneity. It was also shown that the FT-1 antigen molecule carries the receptor for DBA lectin.
